We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

Optimized Freezing Solutions for Clinical Application of Cell Therapy Products

Product News   Sep 02, 2020

 
Optimized Freezing Solutions for Clinical Application of Cell Therapy Products
FURTHER INFORMATION
 
 
Advertisement
 

Related Product News

Long-Acting Peptide Therapy for Heart Failure To Be Developed by AL-Protein and Bioscience

Product News

Antlia Bioscience, Inc., and XL-protein GmbH are pleased to announce a strategic slliance using XL-protein's proprietary PASylation® technology for plasma half-life extension to develop a novel, long-acting, peptide therapeutic treatment for chronic heart failure.

READ MORE

Biopharma Receives Positive EMA Opinion on Orphan Designation for Pancreatic Cancer Treatment

Product News

Prestige BioPharma Ltd. (hereinafter “Prestige BioPharma”) today announced that the European Medicines Agency (EMA) Orphan Drug Commission (COMP) has granted a positive opinion for an Orphan Drug Designation (ODD) status to its first-in-class anti-PAUF monoclonal antibody, PBP1510, for the treatment of pancreatic cancer.

READ MORE

Iksuda Therapeutics Enters Agreement With University of Goettingen To Develop Novel Antibody Drug Conjugates

Product News

Iksuda Therapeutics (Iksuda), today announces it has executed its option to secure exclusive, worldwide rights to develop a novel class of tumour-activated prodrug payloads from the University of Goettingen, following a successful collaboration exemplifying the series in ADC formats.

READ MORE

Like what you just read? You can find similar content on the communities below.

Biopharma

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE